Laprituximab
Product Specifications
CAS Number
1622327-38-1
Target
EGFR
Related Pathways
Angiogenesis|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors
Purity
0.9962
Bioactivity
Laprituximab (J2898A) is a humanized anti-EGFR antibody used for synthesizing ADC compound Laprituximab emtansine.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416316521447634/T77050
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1368425-01 0.02 mg (E-Coli)
Recombinant Vibrio vulnificus 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Ask
View Details MBS1368425-02 0.02 mg (Yeast)
Recombinant Vibrio vulnificus 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Ask
View Details MBS1368425-03 0.1 mg (E-Coli)
Recombinant Vibrio vulnificus 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Ask
View Details